News | Radiation Therapy | January 15, 2016

ASTRO Pledges Support for President’s Commitment to Cancer Research

Society applauds initiative announced in State of the Union address

January 15, 2016 — The American Society for Radiation Oncology (ASTRO) applauded President Obama and Vice President Biden for the “moonshot” effort in cancer research announced in the President’s State of the Union speech on Tuesday.

ASTRO pledged its support of the initiative to bolster resources and foster collaboration among the oncology research community, as well as Vice President Biden’s call in October 2015 to “end cancer as we know it today.”

Despite a two-decade span of decline in cancer death rates, the disease remains a leading source of morbidity and mortality for Americans. The American Cancer Society estimates that nearly 1.7 million Americans will receive cancer diagnoses in 2016, including one in three women and one in two men.

More than half of cancer patients undergo radiation therapy at some point in their treatment, either alone or in conjunction with other treatment options. Existing research demonstrates the effectiveness of radiation therapy as well as its potential in combination with other treatments. ASTRO supports the President’s request to bolster research initiatives that encompass the full range of multidisciplinary therapies in the quest to eradicate cancer.

ASTRO supports research, education and professional training to improve care and outcomes for cancer patients. In 2015 alone, the society provided scientists nearly $1 million through grants and awards supporting radiation oncology research. ASTRO also publishes three medical journals and hosts a variety of scientific meetings in an effort to advance cancer science and help the field avoid the “silos” cautioned in Vice President Biden’s statement, ultimately with the goal of improving patient lives.

For more information: www.astro.org

Related Content

Stronger Distribution Networks to Bolster Radiotherapy Patient Positioning Accessories
News | Patient Positioning Radiation Therapy | July 19, 2019
A recent study projects global market revenues for radiotherapy patient positioning accessories will exceed revenues of...
CMS Proposes New Alternative Payment Model for Radiation Oncology
News | Radiation Oncology | July 17, 2019
The Centers for Medicare and Medicaid Services (CMS) issued a proposal for an advanced alternative payment model (APM)...
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
RaySearch Releases Version 3A of RayCare Oncology Information System
Technology | Oncology Information Management Systems (OIMS) | July 15, 2019
RaySearch has released RayCare 3A, a new version of the next-generation oncology information system (OIS). RayCare is...
IBA Launches Monte Carlo Patient QA for Varian Halcyon at AAPM 2019
Technology | Quality Assurance (QA) | July 10, 2019
IBA announced the launch of the latest functionality of the SciMoCa Monte Carlo Patient QA solution at the 61st annual...
Researchers Use Artificial Intelligence to Deliver Personalized Radiation Therapy
News | Radiation Therapy | July 09, 2019
New Cleveland Clinic-led research shows that artificial intelligence (AI) can use medical scans and health records to...
The Beamscan 3-D water phantom with the Varian Halcyon radiotherapy system

The Beamscan 3-D water phantom with the Varian Halcyon radiotherapy system. Image courtesy of PTW.

News | Quality Assurance (QA) | July 08, 2019
At this year’s American Association of Physicists in Medicine (AAPM) show, July 14-18 in San Antonio, Texas, PTW will...